{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:30:10Z","timestamp":1792467010342,"version":"4.5.0"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":162,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1002\/pds.3762","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T20:48:18Z","timestamp":1427230098000},"page":"518-525","source":"Crossref","is-referenced-by-count":30,"title":["Patient understanding of drug risks: an evaluation of medication guide assessments"],"prefix":"10.1002","volume":"24","author":[{"given":"Caitlin A.","family":"Knox","sequence":"first","affiliation":[{"name":"Pharmaceutical Outcomes and Policy; College of Pharmacy, University of Florida; Gainesville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hampp","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Willy","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Pharmaceutical Outcomes and Policy; College of Pharmacy, University of Florida; Gainesville FL USA"},{"name":"Epidemiology, College of Public Health and Health Professions and College of Medicine; University of Florida; Gainesville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Dal Pan","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"10.1002\/pds.3762-BIB0001|pds3762-cit-0001","unstructured":"Medication guides-distribution requirements and inclusion in Risk Evaluation and Mitigation Strategies (REMS) 2011"},{"key":"10.1002\/pds.3762-BIB0002|pds3762-cit-0002","unstructured":"Risk Evaluation and Mitigation Strategy (REMS) assessments: social science methodologies to assess goals related to knowledge 2012"},{"key":"10.1002\/pds.3762-BIB0003|pds3762-cit-0003","unstructured":"Standardizing and evaluating risk evaluation and mitigation strategies; notice of public meeting; request for comments 2013"},{"key":"10.1002\/pds.3762-BIB0004|pds3762-cit-0004","unstructured":"Strengthening Risk Evaluation and Mitigation Strategies (REMS) Through Systematic Analysis, Standardized Design, and Evidence-Based Assessment 2013"},{"issue":"12","key":"10.1002\/pds.3762-BIB0005|pds3762-cit-0005","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s11606-012-2068-7","article-title":"Usability of FDA-approved medication guides","volume":"27","author":"Wolf","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1002\/pds.3762-BIB0006|pds3762-cit-0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11606-007-0109-4","article-title":"Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions","volume":"22","author":"Allen LaPointe","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1002\/pds.3762-BIB0007|pds3762-cit-0007","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pec.2006.06.010","article-title":"A critical review of FDA-approved medication guides","volume":"62","author":"Wolf","year":"2006","journal-title":"Patient Educ Couns"},{"issue":"5","key":"10.1002\/pds.3762-BIB0008|pds3762-cit-0008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/02770900600709856","article-title":"Readability characteristics of consumer medication information for asthma inhalation devices","volume":"43","author":"Wallace","year":"2006","journal-title":"J Asthma"},{"issue":"4","key":"10.1002\/pds.3762-BIB0009|pds3762-cit-0009","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1345\/aph.1P477","article-title":"Consumer understanding of prescription drug information: an illustration using an antidepressant medication","volume":"45","author":"Shiffman","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1002\/pds.3762-BIB0010|pds3762-cit-0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pds.3400","article-title":"The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey","volume":"22","author":"Enger","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1002\/pds.3762-BIB0011|pds3762-cit-0011","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pds.3450","article-title":"Commentary on \u201cThe effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey\u201d by Enger et al","volume":"22","author":"Dal Pan","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1002\/pds.3762-BIB0012|pds3762-cit-0012","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7326\/0003-4819-145-12-200612190-00144","article-title":"Literacy and misunderstanding prescription drug labels","volume":"145","author":"Davis","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1002\/pds.3762-BIB0013|pds3762-cit-0013","doi-asserted-by":"crossref","DOI":"10.17226\/10883","volume-title":"Health Literacy: A Prescription to End Confusion","author":"Nielsen-Bohlman","year":"2004"},{"key":"10.1002\/pds.3762-BIB0014|pds3762-cit-0014","unstructured":"Standard Definitions Final dispositions of case codes and outcome rates for surveys 2011"},{"key":"10.1002\/pds.3762-BIB0015|pds3762-cit-0015","unstructured":"Census Data United States national population. 2010 http:\/\/2010.census.gov\/2010census\/data\/ 2014"},{"key":"10.1002\/pds.3762-BIB0016|pds3762-cit-0016","unstructured":"Educational Attainment by State U.S. Census Bureau 2011"},{"issue":"2","key":"10.1002\/pds.3762-BIB0017|pds3762-cit-0017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/11597840-000000000-00000","article-title":"Risk evaluation and mitigation strategies (REMS): educating the prescriber","volume":"35","author":"Nicholson","year":"2012","journal-title":"Drug Saf"},{"issue":"6","key":"10.1002\/pds.3762-BIB0018|pds3762-cit-0018","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MLR.0b013e318245a160","article-title":"Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review","volume":"50","author":"Dusetzina","year":"2012","journal-title":"Med Care"},{"issue":"10","key":"10.1002\/pds.3762-BIB0019|pds3762-cit-0019","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF02640361","article-title":"The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills","volume":"10","author":"Parker","year":"1995","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1002\/pds.3762-BIB0020|pds3762-cit-0020","first-page":"433","article-title":"Rapid assessment of literacy levels of adult primary care patients","volume":"23","author":"Davis","year":"1991","journal-title":"Fam Med"},{"issue":"15","key":"10.1002\/pds.3762-BIB0021|pds3762-cit-0021","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2010.263","article-title":"Evaluation of consumer medication information dispensed in retail pharmacies","volume":"170","author":"Winterstein","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1002\/pds.3762-BIB0022|pds3762-cit-0022","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1331\/1544345054475586","article-title":"Expert and consumer evaluation of patient medication leaflets provided in U.S. pharmacies","volume":"45","author":"Svarstad","year":"2005","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3762","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3762","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T20:16:41Z","timestamp":1651609001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3762"}},"subtitle":["PATIENT UNDERSTANDING OF DRUG RISKS"],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3762","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}